Moexipril Hydrochloride (Carilion Materials Management)


Welcome to the PulseAid listing for the Moexipril Hydrochloride drug offered from Carilion Materials Management. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Carilion Materials Management
NON-PROPRIETARY NAME: Moexipril Hydrochloride
SUBSTANCE NAME: MOEXIPRIL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2003-05-08
END MARKETING DATE: 0000-00-00


Moexipril Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMoexipril Hydrochloride from Carilion Materials Management
LABELER NAME: Carilion Materials Management
DEA SCHEDULE:
ACTIVE STRENGTH: 7.5(mg/1)
START MARKETING DATE: 2003-05-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68151-1472_0bbc980f-2958-44e5-bb74-67463ca722de
PRODUCT NDC: 68151-1472
APPLICATION NUMBER: ANDA076204

Other MOEXIPRIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex Corp.Moexipril Hydrochloride
Avera McKennan HospitalMoexipril Hydrochloride
Carilion Materials ManagementMoexipril Hydrochloride
Glenmark Pharmaceuticals Inc., USAMoexipril Hydrochloride
Physicians Total Care, Inc.Moexipril Hydrochloride
Teva Pharmaceuticals USA IncMoexipril Hydrochloride
UCB, Inc.Univasc